Cargando…

Post-Bypass Dexmedetomidine Use and Postoperative Acute Kidney Injury in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass

BACKGROUND: And Objectives: The aim of this retrospective investigation was to study the relationships among chronic kidney disease, acute kidney injury (AKI), and potential benefits by post-bypass dexmedetomidine use in patients undergoing cardiac surgery. METHODS: The patient data were reviewed fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Fuhai, Li, Zhongmin, Young, J. Nilas, Yeranossian, Artin, Liu, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795046/
https://www.ncbi.nlm.nih.gov/pubmed/24130886
http://dx.doi.org/10.1371/journal.pone.0077446
_version_ 1782287325025271808
author Ji, Fuhai
Li, Zhongmin
Young, J. Nilas
Yeranossian, Artin
Liu, Hong
author_facet Ji, Fuhai
Li, Zhongmin
Young, J. Nilas
Yeranossian, Artin
Liu, Hong
author_sort Ji, Fuhai
collection PubMed
description BACKGROUND: And Objectives: The aim of this retrospective investigation was to study the relationships among chronic kidney disease, acute kidney injury (AKI), and potential benefits by post-bypass dexmedetomidine use in patients undergoing cardiac surgery. METHODS: The patient data were reviewed from the institutional Society of Thoracic Surgeons National Adult Cardiac Surgery Database after IRB approval. 1,133 patients were identified and divided into two groups: those who received dexmedetomidine or those who did not during the post-bypass period. The postoperative outcomes include the incidence of AKI, any complication and all cause of mortality. RESULTS: Post-bypass dexmedetomidine use was associated with significantly reduced the incidence of total AKI (26.1% vs. 33.75%; adjusted OR, 0.7033; 95%CI, 0.540 to 0.916; p=0.0089). In addition, post-bypass dexmedetomidine use was more likely to reduce the incidence of AKI in these patients with preoperative normal kidney function (Stage1; 32.8% to 22.8%; p=0.0233) and mild CKD (Stage 2; 32.8% to 24.7; p=0.0003) after cardiac surgery. Post-bypass infusion of dexmedetomidine was associated with significantly reduced incidence of any complication and 30-day mortalities. CONCLUSIONS: Post-bypass dexmedetomidine use is associated with a significant reduction in the incidence of AKI, especially mild AKI in patients with preoperative normal renal function and mild CKD undergoing cardiac surgery.
format Online
Article
Text
id pubmed-3795046
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37950462013-10-15 Post-Bypass Dexmedetomidine Use and Postoperative Acute Kidney Injury in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass Ji, Fuhai Li, Zhongmin Young, J. Nilas Yeranossian, Artin Liu, Hong PLoS One Research Article BACKGROUND: And Objectives: The aim of this retrospective investigation was to study the relationships among chronic kidney disease, acute kidney injury (AKI), and potential benefits by post-bypass dexmedetomidine use in patients undergoing cardiac surgery. METHODS: The patient data were reviewed from the institutional Society of Thoracic Surgeons National Adult Cardiac Surgery Database after IRB approval. 1,133 patients were identified and divided into two groups: those who received dexmedetomidine or those who did not during the post-bypass period. The postoperative outcomes include the incidence of AKI, any complication and all cause of mortality. RESULTS: Post-bypass dexmedetomidine use was associated with significantly reduced the incidence of total AKI (26.1% vs. 33.75%; adjusted OR, 0.7033; 95%CI, 0.540 to 0.916; p=0.0089). In addition, post-bypass dexmedetomidine use was more likely to reduce the incidence of AKI in these patients with preoperative normal kidney function (Stage1; 32.8% to 22.8%; p=0.0233) and mild CKD (Stage 2; 32.8% to 24.7; p=0.0003) after cardiac surgery. Post-bypass infusion of dexmedetomidine was associated with significantly reduced incidence of any complication and 30-day mortalities. CONCLUSIONS: Post-bypass dexmedetomidine use is associated with a significant reduction in the incidence of AKI, especially mild AKI in patients with preoperative normal renal function and mild CKD undergoing cardiac surgery. Public Library of Science 2013-10-10 /pmc/articles/PMC3795046/ /pubmed/24130886 http://dx.doi.org/10.1371/journal.pone.0077446 Text en © 2013 Ji et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Ji, Fuhai
Li, Zhongmin
Young, J. Nilas
Yeranossian, Artin
Liu, Hong
Post-Bypass Dexmedetomidine Use and Postoperative Acute Kidney Injury in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass
title Post-Bypass Dexmedetomidine Use and Postoperative Acute Kidney Injury in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass
title_full Post-Bypass Dexmedetomidine Use and Postoperative Acute Kidney Injury in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass
title_fullStr Post-Bypass Dexmedetomidine Use and Postoperative Acute Kidney Injury in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass
title_full_unstemmed Post-Bypass Dexmedetomidine Use and Postoperative Acute Kidney Injury in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass
title_short Post-Bypass Dexmedetomidine Use and Postoperative Acute Kidney Injury in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass
title_sort post-bypass dexmedetomidine use and postoperative acute kidney injury in patients undergoing cardiac surgery with cardiopulmonary bypass
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795046/
https://www.ncbi.nlm.nih.gov/pubmed/24130886
http://dx.doi.org/10.1371/journal.pone.0077446
work_keys_str_mv AT jifuhai postbypassdexmedetomidineuseandpostoperativeacutekidneyinjuryinpatientsundergoingcardiacsurgerywithcardiopulmonarybypass
AT lizhongmin postbypassdexmedetomidineuseandpostoperativeacutekidneyinjuryinpatientsundergoingcardiacsurgerywithcardiopulmonarybypass
AT youngjnilas postbypassdexmedetomidineuseandpostoperativeacutekidneyinjuryinpatientsundergoingcardiacsurgerywithcardiopulmonarybypass
AT yeranossianartin postbypassdexmedetomidineuseandpostoperativeacutekidneyinjuryinpatientsundergoingcardiacsurgerywithcardiopulmonarybypass
AT liuhong postbypassdexmedetomidineuseandpostoperativeacutekidneyinjuryinpatientsundergoingcardiacsurgerywithcardiopulmonarybypass